SMI
				
					
						12.192,57
					
					PKT
				
				
					
						-42,97
					
					PKT
				
				
					
						-0,35
					
					%
				
			
			
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.01.10 | Nestlé kaufen | Société Générale Group S.A. (SG) | |
| 05.01.10 | Novartis halten | Société Générale Group S.A. (SG) | |
| 05.01.10 | Nestlé verkaufen | JP Morgan Chase & Co. | |
| 06.01.10 | Novartis kaufen | UBS AG | |
| 05.01.10 | Nestlé halten | Independent Research GmbH | |
| 04.01.10 | Novartis halten | Independent Research GmbH | |
| 04.01.10 | Nestlé halten | Independent Research GmbH | |
| 04.01.10 | Novartis halten | SEB AG | |
| 02.01.09 | UBS halten | Raiffeisen Centrobank AG | |
| 04.01.10 | UBS verkaufen | Raiffeisen Centrobank AG | |
| 23.12.09 | Novartis buy | Helvea | |
| 17.12.09 | Swiss Life sell | UBS AG | |
| 22.12.09 | Swiss Life buy | Deutsche Bank AG | |
| 16.12.09 | Swiss Life buy | Société Générale Group S.A. (SG) | |
| 14.12.09 | Zurich Insurance kaufen | Die Actien-Börse | |
| 14.12.09 | Zurich Insurance buy | Deutsche Bank AG | |
| 10.12.09 | Novartis hold | Société Générale Group S.A. (SG) | |
| 11.12.09 | Novartis buy | Citigroup Corp. | |
| 10.12.09 | Zurich Insurance buy | Société Générale Group S.A. (SG) | |
| 09.12.09 | Novartis akkumulieren | Independent Research GmbH | |
| 09.12.09 | Novartis buy | Helvea | |
| 11.12.09 | Novartis buy | Goldman Sachs Group Inc. | |
| 08.12.09 | UBS hold | SEB AG | |
| 08.12.09 | Novartis buy | Citigroup Corp. | |
| 07.12.09 | Holcim buy | Société Générale Group S.A. (SG) | |
| 07.12.09 | Holcim hold | Société Générale Group S.A. (SG) | |
| 03.12.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 03.12.09 | Novartis buy | UBS AG | |
| 30.11.09 | Novartis buy | Helvea | |
| 27.11.09 | Holcim neutral | Goldman Sachs Group Inc. | |
| 26.11.09 | Novartis underperform | Cheuvreux SA | |
| 25.11.09 | Novartis outperform | Exane-BNP Paribas SA | |
| 24.11.09 | Novartis buy | Goldman Sachs Group Inc. | |
| 24.11.09 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.11.09 | Geberit | Focus Money | |
| 18.11.09 | UBS outperform | Credit Suisse Group | |
| 18.11.09 | UBS sell | Société Générale Group S.A. (SG) | |
| 18.11.09 | ABB (Asea Brown Boveri) halten | Oldenburgische LB | |
| 17.11.09 | UBS kaufen | Independent Research GmbH | |
| 17.11.09 | Novartis akkumulieren | Independent Research GmbH | 
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.